Brendan Smith
Stock Analyst at TD Cowen
(4.63)
# 850
Out of 4,455 analysts
261
Total ratings
53.1%
Success rate
17.2%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Rated: Buy | $68 → $89 | $99.84 | -10.86% | 17 | Jun 15, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | n/a | $1.70 | - | 7 | May 27, 2026 | |
| MXCT MaxCyte | Maintained: Buy | n/a | $1.24 | - | 11 | May 12, 2026 | |
| PASG Passage Bio | Reiterated: Hold | n/a | $4.70 | - | 10 | May 12, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $96 | $74.96 | +28.07% | 23 | May 11, 2026 | |
| CERT Certara | Rated: Buy | $10 → $9 | $5.84 | +54.11% | 9 | May 11, 2026 | |
| ABCL AbCellera Biologics | Maintained: Buy | n/a | $7.38 | - | 10 | May 11, 2026 | |
| CDXS Codexis | Maintained: Hold | $2 | $2.39 | -16.32% | 10 | May 7, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | $33 | $28.67 | +15.10% | 11 | May 7, 2026 | |
| DNA Ginkgo Bioworks Holdings | Maintained: Buy | $12 | $10.25 | +17.07% | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.89 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $4.48 | +11.61% | 11 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $2.52 | +19.05% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $20 | $25.50 | -21.57% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.74 | +45.99% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.78 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.52 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.75 | +21.74% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $147.01 | +36.05% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $16.86 | +18.62% | 11 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $350 → $365 | $350.85 | +4.03% | 5 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $16 | $18.20 | -12.09% | 4 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $78.89 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.57 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $9 | $8.88 | n/a | 6 | Nov 12, 2024 |
Twist Bioscience
Jun 15, 2026
Rated: Buy
Price Target: $68 → $89
Current: $99.84
Upside: -10.86%
Rapid Micro Biosystems
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $1.70
Upside: -
MaxCyte
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.24
Upside: -
Passage Bio
May 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.70
Upside: -
Halozyme Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $96
Current: $74.96
Upside: +28.07%
Certara
May 11, 2026
Rated: Buy
Price Target: $10 → $9
Current: $5.84
Upside: +54.11%
AbCellera Biologics
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $7.38
Upside: -
Codexis
May 7, 2026
Maintained: Hold
Price Target: $2
Current: $2.39
Upside: -16.32%
BioLife Solutions
May 7, 2026
Maintained: Buy
Price Target: $33
Current: $28.67
Upside: +15.10%
Ginkgo Bioworks Holdings
May 7, 2026
Maintained: Buy
Price Target: $12
Current: $10.25
Upside: +17.07%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $10.89
Upside: -
May 7, 2026
Maintained: Hold
Price Target: $5
Current: $4.48
Upside: +11.61%
May 7, 2026
Maintained: Buy
Price Target: $3
Current: $2.52
Upside: +19.05%
May 6, 2026
Maintained: Hold
Price Target: $30 → $20
Current: $25.50
Upside: -21.57%
May 6, 2026
Maintained: Buy
Price Target: $4
Current: $2.74
Upside: +45.99%
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $8.78
Upside: -
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $3.52
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $5.75
Upside: +21.74%
May 5, 2026
Maintained: Buy
Price Target: $200
Current: $147.01
Upside: +36.05%
May 5, 2026
Maintained: Buy
Price Target: $20
Current: $16.86
Upside: +18.62%
Apr 23, 2026
Rated: Buy
Price Target: $350 → $365
Current: $350.85
Upside: +4.03%
Apr 9, 2026
Reiterated: Hold
Price Target: $19 → $16
Current: $18.20
Upside: -12.09%
May 13, 2025
Maintained: Buy
Price Target: n/a
Current: $78.89
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: n/a
Current: $25.57
Upside: n/a
Nov 12, 2024
Maintained: Hold
Price Target: $14 → $9
Current: $8.88
Upside: n/a